Funder
Central University Foundation Project
Publisher
Springer Science and Business Media LLC
Subject
Hematology,General Medicine
Reference9 articles.
1. Ojeda MJ, Bragós IM, Calvo KL et al (2017) CALR, JAK2 and MPL mutation status in Argentinean patients with BCR-ABL1- negative myeloproliferative neoplasms. Hematology. 9:1–4
2. Dombi P, Illés Á, Demeter J, Homor L, Simon Z, Kellner Á, Karádi É, Valasinyószki E, Udvardy M, Egyed M (2017) Hungarian Philadelphia negative chronic myeloproliferative neoplasia registry. Evaluation of the polycythemia vera patients. Orv Hetil 158(23):901–909
3. Quintás-Cardama A, Verstovsek S (2013) Molecular pathways: Jak/STAT pathway: mutations, inhibitors, and resistance. Clin Cancer Res 19(8):1933–1940
4. Bahar B, Barton K, Kini AR (2016) The role of the exon 13 G571S JAK2 mutation in myeloproliferative neoplasms. Leuk Res Rep 6:27–28
5. Alghasham N, Alnouri Y, Abalkhail H, Khalil S (2016) Detection of mutations in JAK2 exons 12-15 by Sanger sequencing. Int J Lab Hematol 38(1):34–41